BIO-11006

N/A

Report date: 2025/06/15 20:00:05
NME

Base Information

Drug NameBIO-11006
Drug Alias NameBIO-11006
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionMyristoylated alanine-rich C-kinase substrate inhibitors
TargetsMyristoylated alanine-rich C-kinase substrate
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultPulmonary Disease, Chronic ObstructiveCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiomarck
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomarck Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsRespiratory Distress Syndrome, AdultPulmonary Disease, Chronic ObstructiveCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A